Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03115632 · ClinicalTrials.gov registry record
Contributing Factors in the Pathobiology of Airway Remodeling in Obesity
A clinical trial of Obesity and Asthma, sponsored by Duke University.
- Completed
- Registry status
- 31
- Enrollment target
- 2
- Study locations
NCT03115632 is a study of Obesity and Asthma that has completed, run by Duke University. The registered enrollment target is 31 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03115632, a study of Obesity and Asthma, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
- 2
- Study locations
Study Summary
There are two aims for this study. The purpose of this study is to determine the effects of body weight and hormones on airway fibrosis (scarring) and lung function in obese \& lean asthma subjects compared to obese \& lean non-asthma subjects (Aim 1). And in obese subjects with asthma undergoing bariatric surgery compared to obese non-asthma subjects undergoing bariatric surgery (Aim 2).
Conditions Studied
Study Locations (2)
North Carolina
- Duke Metabolic and Weight Loss Surgery Center - Durham
- Duke Asthma Allergy and Airway Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-04-09 |
| Est. Completion | 2023-06-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03115632
The ClinicalTrials.gov registry entry for NCT03115632 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT03115632 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03115632 about?
NCT03115632 is a clinical study titled "Contributing Factors in the Pathobiology of Airway Remodeling in Obesity". There are two aims for this study. The purpose of this study is to determine the effects of body weight and hormones on airway fibrosis (scarring) and lung function in obese \& lean asthma subjects compared to obese \& lean non-asthma subjects (Aim 1). And in obese subjects with asthma undergoing ba...
What is the current status of trial NCT03115632?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2018-04-09. Estimated completion is 2023-06-27.
What conditions does trial NCT03115632 study?
This clinical trial studies the following conditions: Obesity, Asthma, Bariatric Surgery Candidate, Obesity, Morbid.
Who is sponsoring clinical trial NCT03115632?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03115632 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.